SOD3-Overexpressing Stem Cells for Inflammatory Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic agents for inflammatory diseases often have significant side effects and limited efficacy, with mesenchymal stem cells (MSCs) only exhibiting typical anti-inflammatory effects without optimized potency for inflammation-related diseases.
Innovation Solution
Development of a pharmaceutical composition comprising stem cells overexpressing extracellular superoxide dismutase (SOD3), which enhances immunomodulatory and antioxidative activities, thereby providing a more potent therapeutic option for inflammatory diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional synthetic prophylactic or therapeutic agents for inflammatory diseases are used, then anti-inflammatory efficacy is achieved, but significant side effects occur
Solution Approach 1:
The patent modifies the functional parameters of mesenchymal stem cells by introducing overexpression of SOD3 (superoxide dismutase 3), an enzyme with antioxidant and immunomodulatory properties. This parameter change enhances the cells' anti-inflammatory capabilities while reducing harmful side effects associated with conventional synthetic agents. The SOD3 overexpression alters the biochemical activity profile of MSCs, enabling them to achieve therapeutic efficacy with improved safety profiles.
2Reliability
If typical mesenchymal stem cells are used for treating inflammatory diseases, then some anti-inflammatory effect is achieved, but the potency and effectiveness for inflammation-related diseases is insufficient
Solution Approach 1:
The patent enhances the therapeutic potency of mesenchymal stem cells by changing their enzymatic parameter profile through SOD3 overexpression. This increases the cells' ability to neutralize reactive oxygen species and modulate immune responses, thereby amplifying their anti-inflammatory effect and improving their effectiveness for treating inflammation-related diseases.
Solution Approach 2:
The patent creates a composite functional system by combining mesenchymal stem cells with overexpressing SOD3 enzyme. This composite approach integrates the immunomodulatory properties of MSCs with the potent antioxidant and anti-inflammatory activities of SOD3, resulting in a synergistic therapeutic agent with enhanced potency for treating inflammatory diseases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SOD3-overexpressing stem cells demonstrate enhanced immunosuppressive and anti-inflammatory effects, effectively inhibiting inflammatory responses and promoting regulatory T cell differentiation, offering a promising treatment for inflammatory diseases with reduced side effects.
Implementation Method 1
stem cells overexpressing extracellular superoxide dismutase (SOD3)
Implementation Method 2
extracellular superoxide dismutase (SOD3) for preventing or treating an inflammatory disease
Data Source
AI summary
The present invention provides a pharmaceutical composition for preventing or treating inflammatory diseases, containing, as an active ingredient, stem cells overexpressing SOD3. The present inventor has ascertained that mesenchymal stem cells (MSCs) overexpressing SOD3 have a stronger antioxidant activity and immune regulatory function than normal MSCs, and thus the MSCs overexpressing SOD3 can be an effective treatment agent for inflammatory diseases, autoimmune diseases, organ transplant rejection and the like.